Plexāā Recognized as Innovate UK’s “Most Revolutionary Potential in Women’s Health” at Accelerating Femtech Showcase
[London, February 2023] – Plexāā is proud to announce that they have been awarded the title of “Biggest Potential to be the Most Revolutionary for Women’s Health in the UK” at the 2024 Accelerating Femtech Showcase for their BLOOM⁴³ innovative device which improves healing after breast surgery.
This prestigious recognition comes from an audience of 80 esteemed commissioners, investors, and clinicians, highlighting our commitment to transforming women's health care with our BLOOM⁴³ fist medical device
The Accelerating Femtech Showcase marked the conclusion of an intensive 10-week program aimed at propelling innovation in the Femtech sector.
Dr Saahil Mehta, founder of Plexāā said “ This recognition means the world to me and my dedicated team. We are passionate about developing solutions that will profoundly benefit women undergoing breast surgery. This award validates our efforts and inspires us to continue our mission of improving women's health care globally.”
“We are immensely grateful to the Health Innovation Network South London and Innovate UK for their unwavering support throughout this program. Their resources and guidance have been instrumental in our journey to create impactful solutions for women.”
For more information about Plexāā, please visit www.bloom43.com
About Plexāā
Plexāā is a pioneering UK MedTech company focused on improving surgical outcomes through innovative solutions. Their flagship device, BLOOM⁴³ enables patients to supraphysiologically precondition their skin, potentially reducing the risk of wound healing complications such as infection and skin necrosis, which affect 1 in 3 women undergoing breast surgery.
BLOOM⁴³ is the world’s first fully wearable device worn next to the skin before breast surgery. By gently warming the area to stimulate the release of Heat Shock Proteins (HSPs). These naturally occurring proteins cause the release of carbon monoxide into the tissue which vasodilates the blood vessels and improves the blood flow to the skin. This improved blood flow primes the skin to heal and has been shown to prevent wound healing complications in proof-of-concept clinical trials.
Plexāā is also exploring the application of this technology in other surgical fields, including obstetrics for C-sections, orthopedics for joint operations, and general and vascular surgery, with a commitment to improving pre-operative preparation for surgery and patient outcomes.
Media Contact: